Immunovant (IMVT) has an average rating of buy and mean price target of $46.77, according to analysts polled by FactSet.
(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://finwires.com/en/contact)
Price: $43.85, Change: $-0.52, Percent Change: -1.17%